Home › Politics › EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen
Politics

EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

Key Points

EXCLUSIVE Deals EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter. Qiagen’s board is close to approving the buyout firm’s bid of €46.50 a share and could announce a deal as soon as Wednesday, said the people, who asked not to be identified because the...

EXCLUSIVE Deals EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter. Qiagen’s board is close to approving the buyout firm’s bid of €46.50 a share and could announce a deal as soon as Wednesday, said the people, who asked not to be identified because the information was private. A final decision hasn’t been made, the people said.
Qiagen EQT AB (ORG) Qiagen NV (ORG) European (ORG) Qiagen (ORG)
Originally published by Bloomberg Markets Read original →